SPBC32F12.07c Antibody

What is SPBC32F12.07c and what biological function does it serve in fission yeast?

SPBC32F12.07c is a protein-coding gene in Schizosaccharomyces pombe (fission yeast), identified by UniProt Number O74371 . While the specific biological function is not fully characterized in the available search results, it appears in research related to fission yeast models. The gene exists within a research context involving the TSC pathway, which in fission yeast is involved in nutrient sensing and amino acid uptake mechanisms .

Research indicates the TSC pathway in fission yeast regulates adaptive responses to nitrogen starvation, including changes in amino acid uptake and induction of specific genes like mei2 . Understanding SPBC32F12.07c's potential role in these pathways requires further investigation using specific antibodies and genetic approaches.

What applications has the SPBC32F12.07c antibody been validated for?

The SPBC32F12.07c antibody has been validated for specific applications as documented in product information:

This rabbit polyclonal antibody has been purified by Antigen Affinity methods, making it suitable for protein detection in both native (ELISA) and denatured (Western Blot) states . Researchers should conduct preliminary validation studies if planning to use this antibody for applications beyond those listed, such as immunohistochemistry, immunofluorescence, or chromatin immunoprecipitation.

What are the recommended storage and handling conditions for SPBC32F12.07c antibody?

According to product information, the SPBC32F12.07c antibody should be stored at either -20°C or -80°C for optimal stability and performance . For long-term preservation of antibody activity, -80°C storage is generally preferred.

For maximum retention of antibody function:

• Avoid repeated freeze-thaw cycles

• Aliquot the antibody upon receipt if multiple uses are anticipated

• Allow antibody to reach room temperature before opening

• Centrifuge briefly before use to collect contents at the bottom of the tube

Following these storage recommendations will help maintain antibody specificity and activity for experimental applications.

How can I optimize Western blot protocols specifically for detecting SPBC32F12.07c in fission yeast samples?

Optimizing Western blot protocols for SPBC32F12.07c detection in fission yeast requires careful attention to several critical parameters:

• Sample preparation:

  • For effective lysis of fission yeast cells, incubate approximately 10^10 cells at 37°C for 1 hour in spheroplasts buffer [50 mM citrate-phosphate (pH 5.6)]

  • Include protease inhibitors to prevent degradation of SPBC32F12.07c

  • Ensure complete disruption of the yeast cell wall to release all cellular contents

• Control implementation:

  • Include the 200μg antigens provided with the antibody as positive control

  • Use the 1ml pre-immune serum provided as negative control

  • Consider comparative analysis with wild-type versus knockout strains if available

• Antibody optimization:

  • Test multiple dilutions of the primary antibody to determine optimal concentration

  • Optimize blocking conditions to minimize background (typically 5% non-fat milk or BSA)

  • Consider extended incubation times (overnight at 4°C) for improved signal-to-noise ratio

• Detection strategy:

  • For quantitative analysis, ensure you're working within the linear range of detection

  • Use reference proteins such as tubulin for normalization (anti-tubulin TAT-1 has been used successfully in fission yeast)

  • Document optimization parameters for reproducibility across experiments

What is the relationship between SPBC32F12.07c and the TSC pathway in fission yeast, and how can I design experiments to investigate this?

While the search results don't explicitly define SPBC32F12.07c's role in the TSC pathway, a methodological approach to investigate this relationship would include:

• Experimental design for pathway analysis:

  • Generate expression constructs for tagged versions of SPBC32F12.07c

  • Create knockout or knockdown strains using genetic techniques

  • Analyze phenotypes related to TSC pathway function (amino acid uptake, nitrogen starvation response)

• Protein interaction studies:

  • Perform co-immunoprecipitation with SPBC32F12.07c antibody to identify interacting partners

  • Test for interactions with known TSC pathway components (Tsc1, Tsc2, Rhb1, Tor2)

  • Use yeast two-hybrid or proximity labeling approaches for comprehensive interaction mapping

• Functional assessment:

  • Compare SPBC32F12.07c expression and localization between wild-type and TSC pathway mutants (Δtsc1, Δtsc2)

  • Analyze changes in SPBC32F12.07c protein levels during nitrogen starvation, which activates the TSC pathway

  • Perform epistasis analysis to determine if SPBC32F12.07c functions upstream or downstream of known TSC components

The TSC pathway in fission yeast regulates nutrient sensing, particularly nitrogen starvation responses, which involve changes in amino acid uptake and gene expression patterns . Understanding SPBC32F12.07c's potential role requires systematic investigation using both genetic and biochemical approaches.

How should I develop and validate immunofluorescence protocols using the SPBC32F12.07c antibody?

Developing and validating immunofluorescence protocols for SPBC32F12.07c requires systematic optimization and rigorous controls:

• Fixation method optimization:

  • Test multiple fixation protocols (4% paraformaldehyde, methanol, acetone)

  • Optimize fixation duration and temperature

  • Compare signal intensity and specificity across methods

  • Evaluate preservation of subcellular structures

• Control implementation:

  • Positive controls: Wild-type fission yeast strains expressing SPBC32F12.07c

  • Negative controls: Pre-immune serum provided with the antibody

  • Secondary antibody-only controls to assess non-specific binding

  • Peptide competition assays to confirm signal specificity

• Antibody optimization:

  • Test dilution series (typically starting with 1:50 to 1:500)

  • Optimize incubation conditions (time, temperature, buffer composition)

  • Compare direct versus indirect detection methods

  • Consider signal amplification strategies if needed

• Validation approach:

  • Co-localization with known subcellular markers

  • Correlation with fluorescently tagged SPBC32F12.07c expression

  • Comparison with Western blot results from the same samples

  • Cross-validation using multiple microscopy techniques

Antibody validation in multiple applications serves as a cross-check for specificity and provides additional clarity for researchers . This multi-method validation approach increases confidence in the observed localization patterns.

What are the most effective methods for quantifying SPBC32F12.07c expression levels using this antibody?

Accurate quantification of SPBC32F12.07c expression requires appropriate methodological approaches:

• Western blot-based quantification:

  • Include a dilution series of recombinant SPBC32F12.07c protein to create a standard curve

  • Use the provided 200μg antigen as a reference standard

  • Ensure linear range of detection for both target and loading control

  • Apply densitometric analysis using software like ImageJ

  • Normalize to appropriate loading controls (e.g., tubulin)

• ELISA-based quantification:

  • Develop a sandwich ELISA using this antibody for either capture or detection

  • Create standard curves using purified SPBC32F12.07c protein

  • Ensure samples fall within the linear range of detection

  • Include spike-in controls to assess recovery efficiency

• Statistical considerations:

  • Perform technical triplicates and biological replicates (minimum n=3)

  • Calculate coefficient of variation to assess reproducibility

  • Apply appropriate statistical tests when comparing conditions

  • Document all normalization procedures and analysis parameters

• Validation across methods:

  • Compare protein quantification with transcript levels from RT-qPCR

  • Correlate with fluorescence intensity from immunofluorescence studies

  • Validate findings using orthogonal approaches when possible

This comprehensive approach to quantification provides more reliable data on SPBC32F12.07c expression levels across different experimental conditions.

How does experimental design using the SPBC32F12.07c antibody differ when studying stress responses in fission yeast?

Studying stress responses using SPBC32F12.07c antibody requires specific experimental design considerations:

• Stress condition protocols:

  • Nitrogen starvation: Incubate cells in EMM depleted of nitrogen sources for 3 hours

  • Other stressors: Oxidative stress (H₂O₂), heat shock, osmotic stress, etc.

  • Time-course sampling to capture dynamic protein changes

  • Include unstressed controls for baseline comparison

• Analytical approaches:

  • Western blot analysis to measure total protein level changes

  • Subcellular fractionation to detect translocation events

  • Immunofluorescence to visualize changes in localization pattern

  • Co-immunoprecipitation to identify stress-induced protein interactions

• Experimental controls:

  • Known stress-responsive proteins as positive controls

  • Constitutively expressed proteins as loading controls

  • Time-matched unstressed samples as reference

  • Multiple biological replicates to ensure reproducibility

• Data integration:

  • Correlate protein-level changes with transcriptional responses

  • Compare with published datasets for related stress responses

  • Integrate with phenotypic analysis of cellular responses

  • Consider network analysis to place SPBC32F12.07c in stress-response pathways

Under nitrogen starvation conditions, wild-type fission yeast strains show adaptive responses including changes in amino acid uptake and induction of specific genes . Studying SPBC32F12.07c in this context could reveal its potential role in nutrient sensing and stress adaptation.

What are the potential cross-reactivity concerns with SPBC32F12.07c antibody and how can they be addressed?

Addressing potential cross-reactivity concerns requires systematic validation approaches:

• Sources of cross-reactivity:

  • Proteins with similar epitopes to SPBC32F12.07c

  • Post-translational modifications affecting epitope recognition

  • Non-specific binding to abundant proteins

  • Differences in species-specific isoforms

• Validation methods:

  • Western blot analysis to detect additional bands

  • Immunoprecipitation followed by mass spectrometry identification

  • Peptide competition assays to confirm specific binding

  • Testing across multiple Schizosaccharomyces species

• Control implementation:

  • Pre-immune serum as negative control

  • Recombinant SPBC32F12.07c protein as positive control

  • Testing in knockout/knockdown strains if available

  • Secondary antibody-only controls

• Optimization strategies:

  • Adjust antibody concentration to minimize non-specific binding

  • Increase stringency of washing steps

  • Pre-clear lysates with protein A/G beads before immunoprecipitation

  • Use blocking peptides to confirm signal specificity

Testing on multiple cell lines and in multiple applications serves as a cross-check for specificity . For ubiquitously expressed proteins, knockout/knockdown models provide one of the most trusted ways to ensure specificity .

How can I use SPBC32F12.07c antibody for chromatin immunoprecipitation (ChIP) studies?

While the search results don't specifically mention ChIP applications for SPBC32F12.07c antibody, a methodological approach would include:

• ChIP protocol development:

  • Crosslinking optimization: Test different formaldehyde concentrations (0.75-1.5%) and incubation times

  • Sonication conditions: Adjust to achieve 200-500bp DNA fragments

  • Antibody amount: Typically 2-5μg per ChIP reaction, but requires optimization

  • Washing stringency: Balance between reducing background and maintaining specific interactions

• Control implementation:

  • Input DNA (pre-immunoprecipitation sample)

  • IgG control (non-specific antibody of same isotype)

  • Pre-immune serum provided with the antibody

  • Known genomic regions as positive and negative controls

• ChIP-qPCR validation:

  • Design primers for suspected binding regions

  • Calculate percent input or fold enrichment over IgG

  • Compare enrichment across different genomic regions

  • Establish reproducibility across biological replicates

• ChIP-seq considerations:

  • Library preparation from immunoprecipitated DNA

  • Sequencing depth requirements (typically 10-20 million reads)

  • Computational analysis including peak calling and motif discovery

  • Validation of key findings with targeted ChIP-qPCR

Before proceeding with full ChIP experiments, verify that the antibody can successfully immunoprecipitate SPBC32F12.07c from crosslinked lysates, as ChIP requires antibodies that recognize partially denatured epitopes.

What controls and standards should be used when comparing SPBC32F12.07c expression across different experimental conditions?

Rigorous controls and standards are essential when comparing SPBC32F12.07c expression:

• Experimental controls:

  • Technical replicates (minimum triplicate)

  • Biological replicates (minimum n=3 independent experiments)

  • Positive controls (cells known to express SPBC32F12.07c)

  • Negative controls (knockout strains or pre-immune serum)

• Reference standards:

  • Recombinant SPBC32F12.07c protein as quantitative standard

  • Housekeeping proteins as loading controls (e.g., tubulin)

  • Cells with stable expression of SPBC32F12.07c as reference

  • Standardized lysate preparation to ensure comparable extraction

• Normalization methods:

  • Total protein normalization (Ponceau S, REVERT total protein stain)

  • Housekeeping protein normalization (with verification of stability)

  • Spike-in standards for absolute quantification

  • Multiple normalization methods for cross-validation

• Statistical approach:

  • Appropriate statistical tests based on data distribution

  • Multiple test correction for large-scale experiments

  • Effect size calculation beyond p-value reporting

  • Power analysis to determine required sample size

• Validation strategy:

  • Cross-validation with orthogonal methods (e.g., proteomics, transcriptomics)

  • Independent replication of key findings

  • Correlation with functional assays

  • Verification across different detection methods

This comprehensive approach to controls and standards increases confidence in observed differences in SPBC32F12.07c expression between experimental conditions.

How can I distinguish between specific and non-specific signals when using SPBC32F12.07c antibody in complex applications?

Distinguishing specific from non-specific signals requires systematic validation approaches:

• Control implementation:

  • Use pre-immune serum provided with the antibody as negative control

  • Include antigen blocking (competitive inhibition) controls

  • Employ knockout/knockdown controls when available

  • Test secondary antibody alone to identify non-specific binding

• Signal validation methods:

  • Correlation of signal across multiple detection methods

  • Consistency of signal pattern across experimental replicates

  • Dose-dependent changes in signal with increasing protein amounts

  • Expected molecular weight confirmation in Western blots

• Optimization strategies:

  • Titration of antibody concentration to maximize signal-to-noise ratio

  • Increased blocking stringency to reduce background

  • Extended washing steps to remove weakly bound antibodies

  • Pre-adsorption of antibody with non-specific proteins

• Signal specificity criteria:

  • Signal disappears in competitive inhibition tests

  • Signal is absent in knockout/knockdown samples

  • Signal correlates with expected subcellular localization

  • Signal changes predictably with experimental manipulations

Testing antibodies on multiple cell lines and in multiple applications serves as a cross-check for specificity . Using knockdown or knockout models is one of the most trusted ways to ensure specificity, especially for ubiquitously expressed proteins .

What are the considerations for developing multiplex immunofluorescence protocols that include SPBC32F12.07c antibody?

Developing multiplex immunofluorescence protocols involving SPBC32F12.07c antibody requires careful consideration of several factors:

• Antibody compatibility planning:

  • Select additional antibodies raised in different host species

  • Verify no cross-reactivity between secondary antibodies

  • Consider antibody isotypes for same-species antibodies

  • Test each antibody individually before multiplexing

• Fluorophore selection:

  • Choose fluorophores with minimal spectral overlap

  • Consider signal intensity differences between targets

  • Evaluate autofluorescence profile of your sample

  • Account for photobleaching rates when designing imaging protocols

• Protocol optimization:

  • Sequential vs. simultaneous antibody incubation

  • Antibody concentration adjustment in multiplex setting

  • Fixation method compatibility with all antibodies

  • Antigen retrieval requirements for each target

• Control implementation:

  • Single-stain controls for each antibody

  • Secondary antibody-only controls

  • Spectral unmixing controls if needed

  • Positive and negative biological controls

• Imaging considerations:

  • Appropriate filter sets for clean separation of signals

  • Sequential scanning for confocal microscopy

  • Consistent exposure settings for quantitative analysis

  • Standardized image processing for all experimental groups

This systematic approach ensures reliable multiplex detection of SPBC32F12.07c alongside other proteins of interest, providing valuable insights into protein co-localization and functional relationships.